Stearns, Vered

Publications

Sort by

Co-Author Network

selected publications

A Cohort Study to Evaluate Genetic Predictors for Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS): Results from ECOG-ACRIN E1Z11. Clinical cancer research : an official journal of the American Association for Cancer Research. 2024 Academic Article GET IT
Entinostat, nivolumab and ipilimumab for women with advanced HER2-negative breast cancer: a phase Ib trial. Nature cancer. 2024 Academic Article GET IT
Attempted replication of pharmacogenetic association of variants in PPP1R14C and CCDC148 with aromatase inhibitor-induced musculoskeletal symptoms. Pharmacogenetics and genomics. 2024 Academic Article GET IT
Exploring the links of skeletal muscle mitochondrial oxidative capacity, physical functionality, and mental well-being of cancer survivors. Scientific reports. 2024 Academic Article GET IT
TBCRC 039: a phase II study of preoperative ruxolitinib with or without paclitaxel for triple-negative inflammatory breast cancer. Breast cancer research : BCR. 2024 Academic Article GET IT
Incorporation of emergent symptoms and genetic covariates improves prediction of aromatase inhibitor therapy discontinuation. JAMIA open. 2024 Academic Article GET IT
Polypharmacy, over-the-counter medications, and aromatase inhibitor adherence in early-stage breast cancer. Breast cancer research and treatment. 2024 Academic Article GET IT
Feasibility of DNA Methylation Age as a Biomarker of Symptoms and Resilience among Cancer Survivors with Multiple Chronic Conditions. Biomedicines. 2023 Academic Article GET IT
Feasibility of Symptom Monitoring During the First Year of Endocrine Therapy for Early Breast Cancer Using Patient-Reported Outcomes Collected via Smartphone App. JCO oncology practice. 2023 Academic Article GET IT
Correlation of SUV on Early Interim PET with Recurrence-Free Survival and Overall Survival in Primary Operable HER2-Positive Breast Cancer (the TBCRC026 Trial). Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2023 Academic Article GET IT
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030. Annals of oncology : official journal of the European Society for Medical Oncology. 2023 Academic Article GET IT
Identifying homologous recombination deficiency in breast cancer: genomic instability score distributions differ among breast cancer subtypes. Breast cancer research and treatment. 2023 Academic Article GET IT
Concurrent chemotherapy with partial breast irradiation in triple negative breast cancer patients may improve disease control compared with sequential therapy. Frontiers in oncology. 2023 Academic Article GET IT
Factors associated with weight gain in pre- and post-menopausal women receiving adjuvant endocrine therapy for breast cancer. Journal of cancer survivorship : research and practice. 2023 Academic Article GET IT
Times cited: 1
Circulating tumor DNA association with residual cancer burden after neoadjuvant chemotherapy in triple-negative breast cancer in TBCRC 030. 2023 GET IT
The tumor microenvironment and triple-negative breast cancer aggressiveness: shedding light on mechanisms and targeting. Expert opinion on therapeutic targets. 2023 Academic Article GET IT
Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Academic Article GET IT
Times cited: 37
Automated lesion detection of breast cancer in [¹⁸F] FDG PET/CT using a novel AI-Based workflow. Frontiers in oncology. 2022 Academic Article GET IT
Times cited: 3
Q-122 as a novel, non-hormonal, oral treatment for vasomotor symptoms in women taking tamoxifen or an aromatase inhibitor after breast cancer: a phase 2, randomised, double-blind, placebo-controlled trial. Lancet (London, England). 2022 Academic Article GET IT
Times cited: 5
Factors associated with worsening sexual function during adjuvant endocrine therapy in a prospective clinic-based cohort of women with early-stage breast cancer. Breast cancer research and treatment. 2022 Academic Article GET IT
Genome-wide association study of aromatase inhibitor discontinuation due to musculoskeletal symptoms. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2022 Academic Article GET IT
Times cited: 2
Integrating Immunotherapy in Early-Stage Triple-Negative Breast Cancer: Practical Evidence-Based Considerations. Journal of the National Comprehensive Cancer Network : JNCCN. 2022 Academic Article GET IT
Times cited: 3
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update Q and A. JCO oncology practice. 2022 Academic Article GET IT
Times cited: 1
Development of an automated liquid biopsy assay for methylated markers in advanced breast cancer. Cancer research communications. 2022 Academic Article GET IT
Entinostat Decreases Immune Suppression to Promote Antitumor Responses in a HER2+ Breast Tumor Microenvironment. Cancer immunology research. 2022 Academic Article GET IT
Times cited: 24
Association of treatment-emergent symptoms identified by patient-reported outcomes with adjuvant endocrine therapy discontinuation. NPJ breast cancer. 2022 Academic Article GET IT
Times cited: 10
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Academic Article GET IT
Times cited: 90
A PRO-cision medicine intervention to personalize cancer care using patient-reported outcomes: intervention development and feasibility-testing. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2022 Academic Article GET IT
Times cited: 1
The Breast Cancer Weight Loss trial (Alliance A011401): A description and evidence for the lifestyle intervention. Obesity (Silver Spring, Md.). 2022 Review GET IT
Times cited: 8
Olaparib Use in Patients With Metastatic Breast Cancer Harboring Somatic BRCA1/2 Mutations or Mutations in Non-BRCA1/2, DNA Damage Repair Genes. Clinical breast cancer. 2021 Academic Article GET IT
Times cited: 4
Randomized trial of two artificial intelligence coaching interventions to increase physical activity in cancer survivors. NPJ digital medicine. 2021 Academic Article GET IT
Times cited: 11
Late effects in a high-risk population of breast cancer survivors. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2021 Academic Article GET IT
Times cited: 2
A common goal to CARE: Cancer Advocates, Researchers, and Clinicians Explore current treatments and clinical trials for breast cancer brain metastases. NPJ breast cancer. 2021 Review GET IT
Times cited: 5
Forecasting cancer: from precision to predictive medicine. Med (New York, N.Y.). 2021 Academic Article GET IT
Times cited: 7
The Impact of Radiotherapy Delay in Breast Conservation Patients Not Receiving Chemotherapy and the Rationale for Dichotomizing the Radiation Oncology Time-Dependent Standard into Two Quality Measures. Annals of surgical oncology. 2021 Academic Article GET IT
Times cited: 6
Incidence and Severity of Myelosuppression With Palbociclib After Palliative Bone Radiation in Advanced Breast Cancer: A Single Center Experience and Review of Literature. Clinical breast cancer. 2021 Review GET IT
Times cited: 9
Genome-wide association study of letrozole plasma concentrations identifies non-exonic variants that may affect CYP2A6 metabolic activity. Pharmacogenetics and genomics. 2021 Academic Article GET IT
Times cited: 4
RASAL2 Confers Collateral MEK/EGFR Dependency in Chemoresistant Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Academic Article GET IT
Times cited: 9
Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844). Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Comment GET IT
Times cited: 17
Further Evidence That OPG rs2073618 Is Associated With Increased Risk of Musculoskeletal Symptoms in Patients Receiving Aromatase Inhibitors for Early Breast Cancer. Frontiers in genetics. 2021 Academic Article GET IT
Times cited: 7
Relevance of Platinum-free Interval and BRCA Reversion Mutations for Veliparib Monotherapy after Progression on Carboplatin/Paclitaxel for gBRCA Advanced Breast Cancer (BROCADE3 Crossover). Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Comment GET IT
Times cited: 8
The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote. Journal of cancer survivorship : research and practice. 2021 Academic Article GET IT
Times cited: 3
Updated Results of TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathological Complete Response to Pertuzumab and Trastuzumab in Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Academic Article GET IT
Times cited: 28
Innovating and expanding weight loss strategies for breast cancer survivors. Oncotarget. 2021 Editorial Article GET IT
Times cited: 2
Challenges in Adjuvant Therapy for Premenopausal Women Diagnosed With Luminal Breast Cancers. American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. 2021 Academic Article GET IT
Developing Workshops to Enhance Hope Among Patients With Metastatic Breast Cancer and Oncologists: A Pilot Study. JCO oncology practice. 2021 Academic Article GET IT
Times cited: 11
A randomized intervention involving family to improve communication in breast cancer care. NPJ breast cancer. 2021 Academic Article GET IT
Times cited: 19
Development of new brain metastases in triple negative breast cancer. Journal of neuro-oncology. 2021 Academic Article GET IT
Times cited: 5
Digital Pathology Analysis Quantifies Spatial Heterogeneity of CD3, CD4, CD8, CD20, and FoxP3 Immune Markers in Triple-Negative Breast Cancer. Frontiers in physiology. 2020 Academic Article GET IT
Times cited: 37
Effect of delays in initiation of adjuvant endocrine therapy on survival among women with breast cancer. Breast cancer research and treatment. 2020 Academic Article GET IT
Times cited: 6
Considerations for the Use of Scalp Cooling Devices in Black Patients. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2020 Letter GET IT
Times cited: 10
TBCRC 030: a phase II study of preoperative cisplatin versus paclitaxel in triple-negative breast cancer: evaluating the homologous recombination deficiency (HRD) biomarker. Annals of oncology : official journal of the European Society for Medical Oncology. 2020 Academic Article GET IT
Times cited: 43
Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach. JCO oncology practice. 2020 Academic Article GET IT
Times cited: 40
The effect of 1-day multidisciplinary clinic on breast cancer treatment. Breast cancer research and treatment. 2020 Academic Article GET IT
Times cited: 5
Management of hormone receptor-positive, HER2-negative early breast cancer. Seminars in oncology. 2020 Review GET IT
Times cited: 24
Regulation of the tumor immune microenvironment and vascular normalization in TNBC murine models by a novel peptide. Oncoimmunology. 2020 Academic Article GET IT
Times cited: 12
Clinico-pathologic features, treatment and outcomes of breast cancer during pregnancy or the post-partum period. Breast cancer research and treatment. 2020 Academic Article GET IT
Times cited: 16
Differences in physician opinions about controversial issues surrounding contralateral prophylactic mastectomy (CPM): A survey of physicians from accredited breast centers in the United States. Cancer medicine. 2020 Academic Article GET IT
Times cited: 9
Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors. Frontiers in bioengineering and biotechnology. 2020 Academic Article GET IT
Times cited: 31
The Effects of a Remote-based Weight Loss Program on Adipocytokines, Metabolic Markers, and Telomere Length in Breast Cancer Survivors: the POWER-Remote Trial. Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Academic Article GET IT
Times cited: 22
Dynamic Brain Activity Following Auricular Point Acupressure in Chemotherapy-Induced Neuropathy: A Pilot Longitudinal Functional Magnetic Resonance Imaging Study. Global advances in health and medicine. 2020 Academic Article GET IT
Times cited: 9
Association of Tumor-Infiltrating Lymphocytes with Homologous Recombination Deficiency and BRCA1/2 Status in Patients with Early Triple-Negative Breast Cancer: A Pooled Analysis. Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Academic Article GET IT
Times cited: 17
Reply to A. Katz. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Letter GET IT
Pathogenic Germline Variants in Patients With Metastatic Breast Cancer. JAMA oncology. 2019 Academic Article GET IT
Times cited: 9
High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer. Breast cancer research and treatment. 2019 Academic Article GET IT
Times cited: 14
Intraductal fulvestrant for therapy of ERα-positive ductal carcinoma in situ of the breast: a preclinical study. Carcinogenesis. 2019 Academic Article GET IT
Times cited: 14
Reply to E. Hindié et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Letter GET IT
Reply to H. Brauch et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Letter GET IT
Times cited: 2
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 41
Sharing in care: engaging care partners in the care and communication of breast cancer patients. Breast cancer research and treatment. 2019 Academic Article GET IT
Times cited: 14
Effects of SLCO1B1 polymorphisms on plasma estrogen concentrations in women with breast cancer receiving aromatase inhibitors exemestane and letrozole. Pharmacogenomics. 2019 Academic Article GET IT
Times cited: 7
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: ASCO Clinical Practice Guideline Update-Integration of Results From TAILORx. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 162
Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy. Breast cancer research and treatment. 2019 Academic Article GET IT
Times cited: 6
Treatment Patterns and Outcomes Associated With Palbociclib Plus Letrozole for Postmenopausal Women With HR⁺/HER2^- Advanced Breast Cancer Enrolled in an Expanded Access Program. Clinical breast cancer. 2019 Academic Article GET IT
Times cited: 12
Exemestane may be less detrimental than letrozole to bone health in women homozygous for the UGT2B17*2 gene deletion. Breast cancer research and treatment. 2019 Academic Article GET IT
Times cited: 3
TBCRC026: Phase II Trial Correlating Standardized Uptake Value With Pathologic Complete Response to Pertuzumab and Trastuzumab in Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2019 Academic Article GET IT
Times cited: 32
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: ASCO Clinical Practice Guideline Focused Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2018 Guideline GET IT
Times cited: 337
Survivorship care visits in a high-risk population of breast cancer survivors. Breast cancer research and treatment. 2018 Academic Article GET IT
Times cited: 5
PIK3CA Mutations in Hormone Receptor-Positive Breast Cancers: PIKing Biomarkers to Inform Adjuvant Endocrine Therapy Decisions. JAMA oncology. 2018 Editorial Article GET IT
Times cited: 2
Expanded-Access Study of Palbociclib in Combination With Letrozole for Treatment of Postmenopausal Women With Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer. Clinical breast cancer. 2018 Academic Article GET IT
Times cited: 16
TAILORing Adjuvant Systemic Therapy for Breast Cancer. The New England journal of medicine. 2018 Editorial Article GET IT
Times cited: 3
Breast Hormone Concentrations in Random Fine-Needle Aspirates of Healthy Women Associate with Cytological Atypia and Gene Methylation. Cancer prevention research (Philadelphia, Pa.). 2018 Academic Article GET IT
Times cited: 2
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer. The New England journal of medicine. 2018 Academic Article GET IT
Times cited: 435
CDK4/6 Inhibitors: Game Changers in the Management of Hormone Receptor–Positive Advanced Breast Cancer?. Oncology (Williston Park, N.Y.). 2018 Review GET IT
Times cited: 96
A phase II study evaluating the efficacy of zoledronic acid in prevention of aromatase inhibitor-associated musculoskeletal symptoms: the ZAP trial. Breast cancer research and treatment. 2018 Academic Article GET IT
Times cited: 14
Multiparametric Whole-body MRI with Diffusion-weighted Imaging and ADC Mapping for the Identification of Visceral and Osseous Metastases From Solid Tumors. Academic radiology. 2018 Academic Article GET IT
Times cited: 28
Adiposity Results in Metabolic and Inflammation Differences in Premenopausal and Postmenopausal Women Consistent with the Difference in Breast Cancer Risk. Hormones & cancer. 2018 Academic Article GET IT
Times cited: 12
Increasing Physical Activity Amongst Overweight and Obese Cancer Survivors Using an Alexa-Based Intelligent Agent for Patient Coaching: Protocol for the Physical Activity by Technology Help (PATH) Trial. JMIR research protocols. 2018 Academic Article GET IT
Times cited: 24
Racial disparities in the rate of cardiotoxicity of HER2-targeted therapies among women with early breast cancer. Cancer. 2018 Academic Article GET IT
Times cited: 57
Complete Response to Single-agent Palbociclib in Metastatic Breast Cancer: A Case Report. 2017 GET IT
Times cited: 2
Reply to J.L. Blum et al and S. Lange et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Letter GET IT
Randomized phase III trial evaluating the role of weight loss in adjuvant treatment of overweight and obese women with early breast cancer (Alliance A011401): study design. NPJ breast cancer. 2017 Review GET IT
Times cited: 74
Tumor and serum DNA methylation in women receiving preoperative chemotherapy with or without vorinostat in TBCRC008. Breast cancer research and treatment. 2017 Academic Article GET IT
Times cited: 15
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Focused Update Guideline Summary. Journal of oncology practice. 2017 Academic Article GET IT
Times cited: 24
Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Focused Update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Guideline GET IT
Times cited: 228
Variable aromatase inhibitor plasma concentrations do not correlate with circulating estrogen concentrations in post-menopausal breast cancer patients. Breast cancer research and treatment. 2017 Academic Article GET IT
Times cited: 7
Personalized Medicine in the Oncology Clinic: Implementation and Outcomes of the Johns Hopkins Molecular Tumor Board. JCO precision oncology. 2017 Academic Article GET IT
Times cited: 66
Prospective assessment of patient-reported outcomes and estradiol and drug concentrations in patients experiencing toxicity from adjuvant aromatase inhibitors. Breast cancer research and treatment. 2017 Academic Article GET IT
Times cited: 11
The relationship of single-strand breaks in DNA to breast cancer risk and to tissue concentrations of oestrogens. Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals. 2017 Academic Article GET IT
Times cited: 5
Use of Geriatric Assessment Tools in Selecting Therapies in Women Aged ≥70 Years With Hormone Receptor-Positive Early-Stage Breast Cancer: Preliminary Experience With a Quality Improvement Initiative. International journal of radiation oncology, biology, physics. 2017 Academic Article GET IT
Times cited: 15
The non-receptor tyrosine kinase TNK2/ACK1 is a novel therapeutic target in triple negative breast cancer. Oncotarget. 2017 Academic Article GET IT
Times cited: 32
Combination Epigenetic Therapy in Advanced Breast Cancer with 5-Azacitidine and Entinostat: A Phase II National Cancer Institute/Stand Up to Cancer Study. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 110
Effects of exemestane and letrozole therapy on plasma concentrations of estrogens in a randomized trial of postmenopausal women with breast cancer. Breast cancer research and treatment. 2016 Academic Article GET IT
Times cited: 10
Optimizing the Use of Gene Expression Profiling in Early-Stage Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Academic Article GET IT
Times cited: 49
Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy. Cancer research. 2016 Academic Article GET IT
Times cited: 42
Adjuvant radiation use in older women with early-stage breast cancer at Johns Hopkins. Breast cancer research and treatment. 2016 Academic Article GET IT
Times cited: 16
Polymorphisms in drug-metabolizing enzymes and steady-state exemestane concentration in postmenopausal patients with breast cancer. The pharmacogenomics journal. 2016 Academic Article GET IT
Times cited: 19
ESR1 and PGR polymorphisms are associated with estrogen and progesterone receptor expression in breast tumors. Physiological genomics. 2016 Academic Article GET IT
Times cited: 9
Individualized Molecular Analyses Guide Efforts (IMAGE): A Prospective Study of Molecular Profiling of Tissue and Blood in Metastatic Triple-Negative Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2016 Academic Article GET IT
Times cited: 46
Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk. Cancer prevention research (Philadelphia, Pa.). 2016 Academic Article GET IT
Times cited: 7
New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole - Analyses from NCIC CTG MA.17. Breast (Edinburgh, Scotland). 2016 Academic Article GET IT
Times cited: 5
Patient-Reported Outcomes and Early Discontinuation in Aromatase Inhibitor-Treated Postmenopausal Women With Early Stage Breast Cancer. The oncologist. 2016 Academic Article GET IT
Times cited: 56
A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma. American journal of clinical pathology. 2016 Academic Article GET IT
Times cited: 65
Adjuvant Endocrine Therapy for Women With Hormone Receptor-Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update on Ovarian Suppression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Guideline GET IT
Times cited: 210
Combined Treatment with Epigenetic, Differentiating, and Chemotherapeutic Agents Cooperatively Targets Tumor-Initiating Cells in Triple-Negative Breast Cancer. Cancer research. 2016 Academic Article GET IT
Times cited: 39
Associations between genetic variants and the effect of letrozole and exemestane on bone mass and bone turnover. Breast cancer research and treatment. 2015 Academic Article GET IT
Times cited: 23
Neoadjuvant Therapy for Early-Stage Breast Cancer: Current Practice, Controversies, and Future Directions. Oncology (Williston Park, N.Y.). 2015 Review GET IT
Times cited: 14
Association of Variants in Candidate Genes with Lipid Profiles in Women with Early Breast Cancer on Adjuvant Aromatase Inhibitor Therapy. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 16
Global phosphotyrosine survey in triple-negative breast cancer reveals activation of multiple tyrosine kinase signaling pathways. Oncotarget. 2015 Academic Article GET IT
Times cited: 39
Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer. Molecular & cellular proteomics : MCP. 2015 Academic Article GET IT
Times cited: 20
Gene Mutation Profiling of Breast Cancers for Clinical Decision Making: Drivers and Passengers in the Cart Before the Horse. JAMA oncology. 2015 Academic Article GET IT
Times cited: 3
ACP Journal Club. Tamoxifen for 5 years reduced 16-year risk for breast cancer in women at increased risk. Annals of internal medicine. 2015 Comment GET IT
Multiparametric and Multimodality Functional Radiological Imaging for Breast Cancer Diagnosis and Early Treatment Response Assessment. Journal of the National Cancer Institute. Monographs. 2015 Academic Article GET IT
Times cited: 14
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Academic Article GET IT
Times cited: 349
Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate. Clinical cancer research : an official journal of the American Association for Cancer Research. 2015 Academic Article GET IT
Times cited: 121
Diagnostic accuracy of sentinel node identification is maintained with the addition of local lidocaine and subareolar radioactive colloid injection. Breast cancer research and treatment. 2015 Academic Article GET IT
Times cited: 5
Treatment-associated musculoskeletal and vasomotor symptoms and relapse-free survival in the NCIC CTG MA.27 adjuvant breast cancer aromatase inhibitor trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Academic Article GET IT
Times cited: 36
TBCRC 008: early change in 18F-FDG uptake on PET predicts response to preoperative systemic therapy in human epidermal growth factor receptor 2-negative primary operable breast cancer. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2014 Academic Article GET IT
Times cited: 55
NCCN Working Group report: designing clinical trials in the era of multiple biomarkers and targeted therapies. Journal of the National Comprehensive Cancer Network : JNCCN. 2014 Academic Article GET IT
Times cited: 17
Neoadjuvant chemotherapy and short-term morbidity in patients undergoing mastectomy with and without breast reconstruction. JAMA surgery. 2014 Academic Article GET IT
Times cited: 46
Activation of diverse signalling pathways by oncogenic PIK3CA mutations. Nature communications. 2014 Academic Article GET IT
Times cited: 59
A feasibility study of cyclophosphamide, trastuzumab, and an allogeneic GM-CSF-secreting breast tumor vaccine for HER2+ metastatic breast cancer. Cancer immunology research. 2014 Academic Article GET IT
Times cited: 74
TBCRC 018: phase II study of iniparib in combination with irinotecan to treat progressive triple negative breast cancer brain metastases. Breast cancer research and treatment. 2014 Academic Article GET IT
Times cited: 54
Adjuvant exemestane with ovarian suppression in premenopausal breast cancer. The New England journal of medicine. 2014 Academic Article GET IT
Times cited: 494
Adjuvant endocrine therapy for women with hormone receptor-positive breast cancer: american society of clinical oncology clinical practice guideline focused update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Guideline GET IT
Times cited: 606
Patient-reported symptoms and discontinuation of adjuvant aromatase inhibitor therapy. Cancer. 2014 Academic Article GET IT
Times cited: 71
Effects of adjuvant exemestane versus anastrozole on bone mineral density for women with early breast cancer (MA.27B): a companion analysis of a randomised controlled trial. The Lancet. Oncology. 2014 Academic Article GET IT
Times cited: 46
Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers. Oncotarget. 2014 Academic Article GET IT
Times cited: 350
Detection of cancer DNA in plasma of patients with early-stage breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Academic Article GET IT
Times cited: 332
Patient-reported outcomes in women with breast cancer enrolled in a dual-center, double-blind, randomized controlled trial assessing the effect of acupuncture in reducing aromatase inhibitor-induced musculoskeletal symptoms. Cancer. 2013 Academic Article GET IT
Times cited: 51
Reply to K.I. Pritchard. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Letter GET IT
A PIK3CA mutation detected in plasma from a patient with synchronous primary breast and lung cancers. 2013 GET IT
Times cited: 13
Aromatase inhibitor-induced modulation of breast density: clinical and genetic effects. British journal of cancer. 2013 Academic Article GET IT
Times cited: 23
Statins and Breast Cancer: Future Directions in Chemoprevention. Current breast cancer reports. 2013 Academic Article GET IT
Times cited: 11
Phase II trial of bicalutamide in patients with androgen receptor-positive, estrogen receptor-negative metastatic Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013 Academic Article GET IT
Times cited: 578
Postmenopausal hormone receptor-positive advanced breast cancer. Oncology (Williston Park, N.Y.). 2013 Review GET IT
Times cited: 5
Biomarker modulation following short-term vorinostat in women with newly diagnosed primary breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2013 Academic Article GET IT
Times cited: 26
Optimizing vitamin D concentrations for breast cancer risk reduction. Medicine. 2013 Academic Article GET IT
Times cited: 8
Predictors of recovery of ovarian function during aromatase inhibitor therapy. Annals of oncology : official journal of the European Society for Medical Oncology. 2013 Academic Article GET IT
Times cited: 32
Treatment-emergent effects may predict benefit from endocrine therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Editorial Article GET IT
Times cited: 4
Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer. Breast cancer research and treatment. 2013 Academic Article GET IT
Times cited: 18
Genetic associations with toxicity-related discontinuation of aromatase inhibitor therapy for breast cancer. Breast cancer research and treatment. 2013 Academic Article GET IT
Times cited: 47
Current approaches for neoadjuvant chemotherapy in breast cancer. European journal of pharmacology. 2013 Review GET IT
Times cited: 21
Pharmacogenomics of breast cancer therapy: an update. Pharmacology & therapeutics. 2013 Review GET IT
Times cited: 36
A dual-center randomized controlled double blind trial assessing the effect of acupuncture in reducing musculoskeletal symptoms in breast cancer patients taking aromatase inhibitors. Breast cancer research and treatment. 2013 Academic Article GET IT
Times cited: 74
Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2013 Academic Article GET IT
Times cited: 207
Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer. Cancer. 2012 Academic Article GET IT
Times cited: 165
Cancer support and resource needs among African American older adults. Clinical journal of oncology nursing. 2012 Academic Article GET IT
Times cited: 19
Neuropathy is not associated with clinical outcomes in patients receiving adjuvant taxane-containing therapy for operable breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 78
Epigenetics as a therapeutic target in breast cancer. Journal of mammary gland biology and neoplasia. 2012 Review GET IT
Times cited: 100
Intraductal administration of a polymeric nanoparticle formulation of curcumin (NanoCurc) significantly attenuates incidence of mammary tumors in a rodent chemical carcinogenesis model: Implications for breast cancer chemoprevention in at-risk populations. Carcinogenesis. 2012 Academic Article GET IT
Times cited: 54
Intraductally administered pegylated liposomal doxorubicin reduces mammary stem cell function in the mammary gland but in the long term, induces malignant tumors. Breast cancer research and treatment. 2012 Academic Article GET IT
Times cited: 19
Whole genome amplification of DNA for genotyping pharmacogenetics candidate genes. Frontiers in pharmacology. 2012 Academic Article GET IT
Times cited: 2
Transient low doses of DNA-demethylating agents exert durable antitumor effects on hematological and epithelial tumor cells. Cancer cell. 2012 Academic Article GET IT
Times cited: 510
Detection of tumor PIK3CA status in metastatic breast cancer using peripheral blood. Clinical cancer research : an official journal of the American Association for Cancer Research. 2012 Academic Article GET IT
Times cited: 284
CYP2D6 and UGT2B7 genotype and risk of recurrence in tamoxifen-treated breast cancer patients. Journal of the National Cancer Institute. 2012 Academic Article GET IT
Times cited: 235
Predictors of aromatase inhibitor discontinuation as a result of treatment-emergent symptoms in early-stage breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Academic Article GET IT
Times cited: 290
Race and hormone receptor-positive breast cancer outcomes in a randomized chemotherapy trial. Journal of the National Cancer Institute. 2012 Academic Article GET IT
Times cited: 86
Phase I-II study of vorinostat plus paclitaxel and bevacizumab in metastatic breast cancer: evidence for vorinostat-induced tubulin acetylation and Hsp90 inhibition in vivo. Breast cancer research and treatment. 2011 Academic Article GET IT
Times cited: 67
A SNP in steroid receptor coactivator-1 disrupts a GSK3β phosphorylation site and is associated with altered tamoxifen response in bone. Molecular endocrinology (Baltimore, Md.). 2011 Academic Article GET IT
Times cited: 15
Comparison of changes in the lipid profile of postmenopausal women with early stage breast cancer treated with exemestane or letrozole. Journal of clinical pharmacology. 2011 Academic Article GET IT
Times cited: 28
Effect of simvastatin on the pharmacokinetics of anastrozole. Breast cancer research and treatment. 2011 Academic Article GET IT
Times cited: 6
A short-term biomarker modulation study of simvastatin in women at increased risk of a new breast cancer. Breast cancer research and treatment. 2011 Academic Article GET IT
Times cited: 55
Comparison of breast cancer recurrence risk and cardiovascular disease incidence risk among postmenopausal women with breast cancer. Breast cancer research and treatment. 2011 Academic Article GET IT
Times cited: 56
Preclinical and clinical evaluation of intraductally administered agents in early breast cancer. Science translational medicine. 2011 Academic Article GET IT
Times cited: 65
Plasma letrozole concentrations in postmenopausal women with breast cancer are associated with CYP2A6 genetic variants, body mass index, and age. Clinical pharmacology and therapeutics. 2011 Academic Article GET IT
Times cited: 83
Changes in breast density and circulating estrogens in postmenopausal women receiving adjuvant anastrozole. Cancer prevention research (Philadelphia, Pa.). 2011 Academic Article GET IT
Times cited: 22
Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer. Cancer biology & therapy. 2011 Academic Article GET IT
Times cited: 46
Monitoring of neoadjuvant chemotherapy using multiparametric, ²³Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer. Breast cancer research and treatment. 2011 Academic Article GET IT
Times cited: 66
Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management. Breast cancer research : BCR. 2011 Review GET IT
Times cited: 92
Docetaxel metabolism is not altered by imatinib: findings from an early phase study in metastatic breast cancer. Breast cancer research and treatment. 2011 Academic Article GET IT
Times cited: 15
Pharmacogenetics of endocrine therapy for breast cancer. Annual review of medicine. 2011 Review GET IT
Times cited: 47
In vitro and in vivo oxidative metabolism and glucuronidation of anastrozole. British journal of clinical pharmacology. 2010 Academic Article GET IT
Times cited: 69
One size does not fit all: quality of life during adjuvant aromatase inhibitor therapy. Breast cancer research and treatment. 2010 Academic Article GET IT
Times cited: 2
Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Academic Article GET IT
Times cited: 176
Multiparametric magnetic resonance imaging, spectroscopy and multinuclear (²³Na) imaging monitoring of preoperative chemotherapy for locally advanced breast cancer. Academic radiology. 2010 Academic Article GET IT
Times cited: 48
A prospective study of aromatase inhibitor-associated musculoskeletal symptoms and abnormalities on serial high-resolution wrist ultrasonography. Cancer. 2010 Academic Article GET IT
Times cited: 32
Estrogen receptor genotypes, menopausal status, and the effects of tamoxifen on lipid levels: revised and updated results. Clinical pharmacology and therapeutics. 2010 Academic Article GET IT
Times cited: 14
Personalized tamoxifen: a step closer but miles to go. Clinical cancer research : an official journal of the American Association for Cancer Research. 2010 Comment GET IT
Times cited: 5
American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2010 Guideline GET IT
Times cited: 604
DNA methylation-related vitamin D receptor insensitivity in breast cancer. Cancer biology & therapy. 2010 Academic Article GET IT
Times cited: 93
Inflammatory cytokines and aromatase inhibitor-associated musculoskeletal syndrome: a case-control study. British journal of cancer. 2010 Academic Article GET IT
Times cited: 32
Preferences for hypnotic imagery for hot-flash reduction: a brief communication. The International journal of clinical and experimental hypnosis. 2010 Academic Article GET IT
Times cited: 5
Intraductal therapy for the prevention of breast cancer. Current opinion in investigational drugs (London, England : 2000). 2010 Review GET IT
Times cited: 10
Modeling hot flushes and quality of life in breast cancer survivors. Climacteric : the journal of the International Menopause Society. 2010 Academic Article GET IT
Times cited: 43
Needs assessments can identify scores on HRQOL questionnaires that represent problems for patients: an illustration with the Supportive Care Needs Survey and the QLQ-C30. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2010 Academic Article GET IT
Times cited: 43
Personal breast: customizing agents and biomarkers for optimal adjuvant endocrine therapy. Breast cancer research and treatment. 2010 Comment GET IT
Times cited: 3
A multidisciplinary approach to neoadjuvant therapy for primary operable breast cancer. Challenges and opportunities. Oncology (Williston Park, N.Y.). 2010 Academic Article GET IT
Times cited: 6
Pathologic complete response to preoperative sequential doxorubicin/cyclophosphamide and single-agent taxane with or without trastuzumab in stage II/III HER2-positive breast cancer. Clinical breast cancer. 2010 Academic Article GET IT
Times cited: 15
Epigenetic regulation in estrogen receptor positive breast cancer--role in treatment response. Journal of mammary gland biology and neoplasia. 2010 Review GET IT
Times cited: 43
Composite functional genetic and comedication CYP2D6 activity score in predicting tamoxifen drug exposure among breast cancer patients. Journal of clinical pharmacology. 2010 Academic Article GET IT
Times cited: 106
CYP2D6 polymorphisms and tamoxifen metabolism: clinical relevance. Current oncology reports. 2010 Review GET IT
Times cited: 53
Lack of association between oestrogen receptor polymorphisms and change in bone mineral density with tamoxifen therapy. British journal of cancer. 2009 Academic Article GET IT
Times cited: 17
The biology of hormone refractory breast and prostate cancer: An NCI workshop report. Cancer biology & therapy. 2009 Conference Paper GET IT
Times cited: 20
Severe prolonged cholestatic hepatitis caused by exemestane. 2009 GET IT
Times cited: 4
Timed sequential treatment with cyclophosphamide, doxorubicin, and an allogeneic granulocyte-macrophage colony-stimulating factor-secreting breast tumor vaccine: a chemotherapy dose-ranging factorial study of safety and immune activation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 212
Concordance of cancer patients' function, symptoms, and supportive care needs. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2009 Academic Article GET IT
Times cited: 38
African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Letter GET IT
Times cited: 18
Understanding resistance to tamoxifen in hormone receptor-positive breast cancer. Clinical chemistry. 2009 Academic Article GET IT
Times cited: 30
Cytochrome P450 2D6 activity predicts discontinuation of tamoxifen therapy in breast cancer patients. The pharmacogenomics journal. 2009 Academic Article GET IT
Times cited: 74
Treatment strategies for hot flushes. Expert opinion on pharmacotherapy. 2009 Review GET IT
Times cited: 38
Feasibility trial of partial breast irradiation with concurrent dose-dense doxorubicin and cyclophosphamide in early-stage breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 15
Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Academic Article GET IT
Times cited: 154
Tamoxifen metabolism and its effect on endocrine treatment of breast cancer. Clinical advances in hematology & oncology : H&O. 2009 Review GET IT
Times cited: 31
Pharmacogenetics of tamoxifen: who should undergo CYP2D6 genetic testing?. Journal of the National Comprehensive Cancer Network : JNCCN. 2009 Review GET IT
Times cited: 57
Association between CYP2D6 genotype and tamoxifen-induced hot flashes in a prospective cohort. Breast cancer research and treatment. 2009 Academic Article GET IT
Times cited: 66
Comparison of subjective and objective hot flash measures over time among breast cancer survivors initiating aromatase inhibitor therapy. Menopause (New York, N.Y.). 2009 Academic Article GET IT
Times cited: 24
Newer antidepressants and gabapentin for hot flashes: a discussion of trial duration. Menopause (New York, N.Y.). 2009 Review GET IT
Times cited: 22
Pharmacogenetics and breast cancer endocrine therapy: CYP2D6 as a predictive factor for tamoxifen metabolism and drug response?. Expert reviews in molecular medicine. 2008 Review GET IT
Times cited: 32
Estrogen receptor genotypes influence hot flash prevalence and composite score before and after tamoxifen therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 39
Aromatase inhibitor-associated musculoskeletal symptoms: etiology and strategies for management. Oncology (Williston Park, N.Y.). 2008 Comment GET IT
Times cited: 62
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression. The American journal of psychiatry. 2008 Review GET IT
Times cited: 83
Randomized trial of a hypnosis intervention for treatment of hot flashes among breast cancer survivors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Academic Article GET IT
Times cited: 172
Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer. Annals of oncology : official journal of the European Society for Medical Oncology. 2008 Review GET IT
Times cited: 98
Symptoms, supportive care needs, and function in cancer patients: how are they related?. Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation. 2008 Academic Article GET IT
Times cited: 46
A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?. Journal of the National Cancer Institute. 2008 Editorial Article GET IT
Times cited: 37
A diet low in fat and high in vegetables, fruit, and fiber following breast cancer treatment did not reduce new breast cancer events. ACP journal club. 2008 Comment GET IT
Adjuvant aromatase inhibitors and emerging quality-of-life considerations. Expert review of anticancer therapy. 2008 Editorial Article GET IT
Times cited: 3
Extended adjuvant therapy for breast cancer--how much is enough?. Journal of the National Cancer Institute. 2007 Editorial Article GET IT
Times cited: 1
Epigenetic regulation as a new target for breast cancer therapy. Cancer investigation. 2007 Review GET IT
Times cited: 70
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: new perspectives 2006. Annals of oncology : official journal of the European Society for Medical Oncology. 2007 Review GET IT
Times cited: 321
Prospective characterization of musculoskeletal symptoms in early stage breast cancer patients treated with aromatase inhibitors. Breast cancer research and treatment. 2007 Academic Article GET IT
Times cited: 198
Chemotherapeutic Strategies for advanced breast cancer. Oncology (Williston Park, N.Y.). 2007 Review GET IT
Times cited: 11
Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. Clinical pharmacology and therapeutics. 2007 Academic Article GET IT
Times cited: 36
Clinical update: new treatments for hot flushes. Lancet (London, England). 2007 Academic Article GET IT
Times cited: 32
Advances in the adjuvant and neoadjuvant treatment of breast cancer. Women's health (London, England). 2007 Academic Article GET IT
Times cited: 1
Pilot evaluation of hypnosis for the treatment of hot flashes in breast cancer survivors. Psycho-oncology. 2007 Academic Article GET IT
Times cited: 47
Elevated tissue sodium concentration in malignant breast lesions detected with non-invasive 23Na MRI. Breast cancer research and treatment. 2007 Academic Article GET IT
Times cited: 155
Role of CYP2D6 testing in selection of endocrine therapy for breast cancer. Pharmacogenomics. 2007 Editorial Article GET IT
Times cited: 8
Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased risk. Evidence-based medicine. 2006 Comment GET IT
Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. Nature reviews. Cancer. 2006 Review GET IT
Times cited: 74
Lymphadenopathy resulting from acute hepatitis C infection mimicking metastatic breast carcinoma on FDG PET/CT. 2006 GET IT
Times cited: 23
Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment. Clinical pharmacology and therapeutics. 2006 Academic Article GET IT
Times cited: 439
Effects of pegfilgrastim on normal biodistribution of 18F-FDG: preclinical and clinical studies. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2006 Academic Article GET IT
Times cited: 50
Myeloid toxicity in breast cancer patients receiving adjuvant chemotherapy with pegfilgrastim support. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Letter GET IT
Times cited: 17
Lipophilic statins merit additional study for breast cancer chemoprevention. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Letter GET IT
Times cited: 19
Recommendations from an international expert panel on the use of neoadjuvant (primary) systemic treatment of operable breast cancer: an update. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Guideline GET IT
Times cited: 537
Chemoprevention of breast cancer: tamoxifen, raloxifene, and beyond. American journal of therapeutics. 2006 Review GET IT
Times cited: 20
Disease-free survival was greater with letrozole than tamoxifen in postmenopausal women with early breast cancer. ACP journal club. 2006 Comment GET IT
More choices, more questions: weighing the options for treating hot flashes. The journal of supportive oncology. 2006 Comment GET IT
Raloxifene and tamoxifen had similar efficacy for preventing invasive breast cancer in women at increased risk. ACP journal club. 2006 Comment GET IT
Serotonergic agents as an alternative to hormonal therapy for the treatment of menopausal vasomotor symptoms. Treatments in endocrinology. 2006 Academic Article GET IT
Times cited: 31
Centrally active nonhormonal hot flash therapies. The American journal of medicine. 2005 Conference Paper GET IT
Times cited: 37
Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Academic Article GET IT
Times cited: 209
CYP2D6 genotype and tamoxifen response. Breast cancer research : BCR. 2005 Letter GET IT
Times cited: 15
CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. Journal of the National Cancer Institute. 2005 Academic Article GET IT
Times cited: 852
A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 11
Multiparametric and multinuclear magnetic resonance imaging of human breast cancer: current applications. Technology in cancer research & treatment. 2004 Academic Article GET IT
Times cited: 37
A pilot surrogate end point biomarker trial of perillyl alcohol in breast neoplasia. Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 Academic Article GET IT
Times cited: 19
Can hypnosis reduce hot flashes in breast cancer survivors? A literature review. The American journal of clinical hypnosis. 2004 Review GET IT
Times cited: 24
Management of hot flashes in breast cancer survivors and men with prostate cancer. Current oncology reports. 2004 Review GET IT
Times cited: 11
Déjà vu for breast cancer two?. Journal of the National Cancer Institute. 2004 Editorial Article GET IT
Times cited: 2
A phase I vaccine safety and chemotherapy dose-finding trial of an allogeneic GM-CSF-secreting breast cancer vaccine given in a specifically timed sequence with immunomodulatory doses of cyclophosphamide and doxorubicin. Human gene therapy. 2004 Academic Article GET IT
Times cited: 34
Pharmacogenetics in the treatment of breast cancer. The pharmacogenomics journal. 2004 Review GET IT
Times cited: 49
Active tamoxifen metabolite plasma concentrations after coadministration of tamoxifen and the selective serotonin reuptake inhibitor paroxetine. Journal of the National Cancer Institute. 2003 Academic Article GET IT
Times cited: 789
Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial. JAMA. 2003 Academic Article GET IT
Times cited: 457
A prospective randomized pilot study to evaluate predictors of response in serial core biopsies to single agent neoadjuvant doxorubicin or paclitaxel for patients with locally advanced breast cancer. Clinical cancer research : an official journal of the American Association for Cancer Research. 2003 Academic Article GET IT
Times cited: 102
New therapeutic approaches for hot flashes in women. The journal of supportive oncology. 2003 Review GET IT
Times cited: 21
Hot flushes. Lancet (London, England). 2002 Review GET IT
Times cited: 352
Development and validation of a method for using breast core needle biopsies for gene expression microarray analyses. Clinical cancer research : an official journal of the American Association for Cancer Research. 2002 Academic Article GET IT
Times cited: 100
Approach to menopausal symptoms in women with breast cancer. Current treatment options in oncology. 2002 Academic Article GET IT
Times cited: 16
Sentinel lymphadenectomy after neoadjuvant chemotherapy for breast cancer may reliably represent the axilla except for inflammatory breast cancer. Annals of surgical oncology. 2002 Academic Article GET IT
Times cited: 242
Cooling off hot flashes. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Editorial Article GET IT
Times cited: 16
Prognostic factors in breast cancer: current and new predictors of metastasis. Journal of mammary gland biology and neoplasia. 2001 Review GET IT
Times cited: 193
When is a tumor marker ready for prime time? A case study of c-erbB-2 as a predictive factor in breast cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Review GET IT
Times cited: 283
New prognostic factors for breast cancer recurrence. Seminars in oncology. 2001 Review GET IT
Times cited: 89
The Role of c-erbB-2 as a predictive factor in breast cancer. Breast cancer (Tokyo, Japan). 2001 Review GET IT
Times cited: 34
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Annals of oncology : official journal of the European Society for Medical Oncology. 2000 Academic Article GET IT
Times cited: 222
Does tamoxifen cause cancer in humans?. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1998 Review GET IT
Times cited: 64
Circulating tumor markers in breast cancer: accepted utilities and novel prospects. Breast cancer research and treatment. 1998 Review GET IT
Times cited: 81

more ...

less ...

Research

Sort by

Co-investigator Network

Funding awarded

New Approaches to Breast Cancer Prevention awarded by Breast Cancer Research Foundation, Inc. Principal Investigator 2023 - 2024

NRG Oncology Network Group Operations Center awarded by National Cancer Institute Principal Investigator Subaward 2023 - 2024

more ...

less ...

Background

education and training

M.D., University of Medicine and Dentistry of New Jersey 1992

Contact

full name

Vered Stearns

primary email

ves4007@med.cornell.edu

webpage

Clinical Profile

VIVO Weill Cornell Medical College

Vered Stearns Professor of Medicine (Pending Appointment at Rank)

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage

Phone

Publications

selected publications

Research

Funding awarded

Background

education and training

Contact

full name

primary email

webpage